A Phase I Study to Evaluate the Pharmacokinetic Drug.Drug Interaction of HP501, Febuxostat, and Colchicine in Male Chinese Patients with Hyperuricemia

Ding, RL; Chen, LX; Li, XH; Xiong, TQ; Chen, H; Hu, XJ; Li, Y; Zhou, Y; Liu, KZ; Wu, JH; Jiang, F; Peng, Q

Jiang, F; Peng, Q (通讯作者)，Southwest Med Univ, Dept Cardiol, Affiliated Hosp, 25 Taiping St, Luzhou 646000, Peoples R China.

CLINICAL DRUG INVESTIGATION, 2023; 43 (6): 401

Abstract

Background and Objective HP501 is a highly selective renal urate transporter 1 (URAT1) inhibitor that is being developed for the treatment of hyperuri......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索